DE69936779D1 - Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen - Google Patents

Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen

Info

Publication number
DE69936779D1
DE69936779D1 DE69936779T DE69936779T DE69936779D1 DE 69936779 D1 DE69936779 D1 DE 69936779D1 DE 69936779 T DE69936779 T DE 69936779T DE 69936779 T DE69936779 T DE 69936779T DE 69936779 D1 DE69936779 D1 DE 69936779D1
Authority
DE
Germany
Prior art keywords
treatment
ngali
oil
arthritiserial
nuth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69936779T
Other languages
English (en)
Other versions
DE69936779T2 (de
Inventor
Peter Hugh Hull
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69936779D1 publication Critical patent/DE69936779D1/de
Application granted granted Critical
Publication of DE69936779T2 publication Critical patent/DE69936779T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Lubricants (AREA)
DE69936779T 1998-06-01 1999-06-01 Die verwendung von ngali-nussöl zur behandlung/linderung der manifestationen von arthritis und anderen ähnlichen zuständen Expired - Lifetime DE69936779T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP379698 1998-06-01
AUPP3796A AUPP379698A0 (en) 1998-06-01 1998-06-01 Using ngali nut oil to treat/relieve the pain of arthritis and other similar conditions
PCT/AU1999/000426 WO1999062528A1 (en) 1998-06-01 1999-06-01 Treatment of arthritis and other similar conditions

Publications (2)

Publication Number Publication Date
DE69936779D1 true DE69936779D1 (de) 2007-09-20
DE69936779T2 DE69936779T2 (de) 2008-07-31

Family

ID=3808043

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69936779T Expired - Lifetime DE69936779T2 (de) 1998-06-01 1999-06-01 Die verwendung von ngali-nussöl zur behandlung/linderung der manifestationen von arthritis und anderen ähnlichen zuständen

Country Status (13)

Country Link
US (1) US6395313B1 (de)
EP (1) EP1083914B1 (de)
JP (1) JP4583599B2 (de)
CN (1) CN1251707C (de)
AT (1) ATE369143T1 (de)
AU (2) AUPP379698A0 (de)
CA (1) CA2330659C (de)
DE (1) DE69936779T2 (de)
ID (1) ID27052A (de)
IL (1) IL139303A0 (de)
NZ (2) NZ507764A (de)
WO (1) WO1999062528A1 (de)
ZA (1) ZA200006406B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005053718A1 (en) * 2003-12-05 2005-06-16 Naturaleaf, Inc. Methods and compositions for treating inflammatory and dermatological conditions
US20060068004A1 (en) * 2004-09-28 2006-03-30 Aum Nutrapharm Inc. Buccal delivery of sea cucumber tablets
US7794413B2 (en) * 2005-04-19 2010-09-14 Ev3, Inc. Libraries and data structures of materials removed by debulking catheters
US20070048386A1 (en) * 2005-08-30 2007-03-01 Mallozzi Ottavio Sr Medicament for treating inflammatory and non-inflammatory arthritis
WO2011122927A1 (en) * 2010-03-31 2011-10-06 Universiti Putra Malaysia A vegetable oil and/or fats
MY190725A (en) 2013-12-24 2022-05-12 Biotropics Malaysia Bhd Fruit extracts and extract formulations of canarium odontophyllum as actives and related invention embodiments

Also Published As

Publication number Publication date
NZ525536A (en) 2004-12-24
CN1251707C (zh) 2006-04-19
EP1083914A1 (de) 2001-03-21
AU746083B2 (en) 2002-04-11
US6395313B1 (en) 2002-05-28
IL139303A0 (en) 2001-11-25
JP2003523920A (ja) 2003-08-12
NZ507764A (en) 2003-07-25
CA2330659A1 (en) 1999-12-09
AU746083C (en) 2002-12-05
WO1999062528A1 (en) 1999-12-09
ZA200006406B (en) 2002-05-08
AUPP379698A0 (en) 1998-06-25
ATE369143T1 (de) 2007-08-15
EP1083914B1 (de) 2007-08-08
EP1083914A4 (de) 2002-09-18
JP4583599B2 (ja) 2010-11-17
DE69936779T2 (de) 2008-07-31
CN1303297A (zh) 2001-07-11
ID27052A (id) 2001-02-22
AU4249199A (en) 1999-12-20
CA2330659C (en) 2010-11-16

Similar Documents

Publication Publication Date Title
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69815090D1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
EA199800667A1 (ru) Новые фенантридины
ATE279181T1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
ATE275608T1 (de) Behandlung von mineralfüllstoffen mit phosphaten, diese füllstoffe und deren verwendung
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
ATE555803T1 (de) Verwendung von osteopontin zur behandlung und/oder vorbeugung von neurologischen erkrankungen
DE69825440D1 (de) VERWENDUNG VON TAUROLIDINE ZUR Herstellung eines Arzneimittels zur BEHANDLUNG VON LEUKÄMIEN
DE69524623T2 (de) Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
DE69912670D1 (de) Substituierte tricyclische Verbindungen und deren Verwendung zur Behandlung von sPLA2-bedingten Erkrankungen
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE69936779D1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ATE206052T1 (de) Verwendung von sphingosin-1-phosphat, sphingosin- 1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
ATE243514T1 (de) Verwendung von darifenacin zur verbesserung der wahrnehmung
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
DE69930725D1 (de) Verfahren und kits zur behandlung von vulvovaginalen candidosen mit mikonazolnitrat
DE3586420D1 (de) Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.
DE69926996D1 (de) Verwendung von riluzol zur behandlung der retinalischemie
DE59904564D1 (de) Verwendung von acetylcholinesterase-inhibitoren zur behandlung von delirien
ATE275949T1 (de) Verwendung von diminazen-di-aceturat und/oder pentamidin zur behandlung von malaria
DE69712287T2 (de) Verwendung von Sulbutiamin zur Behandlung von psychomotorischen oder psychointellektuellen Beschwerden
ATE204167T1 (de) Antikonvulsive derivate zur behandlung von psoriasis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition